These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

413 related items for PubMed ID: 17549304

  • 1. Comparative characterization of cellular and molecular anti-restenotic profiles of paclitaxel and sirolimus. Implications for local drug delivery.
    Wessely R, Blaich B, Belaiba RS, Merl S, Görlach A, Kastrati A, Schömig A.
    Thromb Haemost; 2007 Jun; 97(6):1003-12. PubMed ID: 17549304
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Comparative assessment of transient exposure of paclitaxel or zotarolimus on in vitro vascular cell death, proliferation, migration, and proinflammatory biomarker expression.
    Steinfeld DS, Liu AP, Hsu SH, Chan YF, Stankus JJ, Pacetti SD, Tai JT.
    J Cardiovasc Pharmacol; 2012 Aug; 60(2):179-86. PubMed ID: 22561362
    [Abstract] [Full Text] [Related]

  • 5. Drug-eluting stents: sirolimus and paclitaxel differentially affect cultured cells and injured arteries.
    Parry TJ, Brosius R, Thyagarajan R, Carter D, Argentieri D, Falotico R, Siekierka J.
    Eur J Pharmacol; 2005 Nov 07; 524(1-3):19-29. PubMed ID: 16271360
    [Abstract] [Full Text] [Related]

  • 6. Sirolimus and Paclitaxel on polymer-based drug-eluting stents: similar but different.
    Wessely R, Schömig A, Kastrati A.
    J Am Coll Cardiol; 2006 Feb 21; 47(4):708-14. PubMed ID: 16487832
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparative healing response after sirolimus- and paclitaxel-eluting stent implantation in a pig model of restenosis.
    Silva GV, Fernandes MR, Madonna R, Clubb F, Oliveira E, Jimenez-Quevedo P, Branco R, Lopez J, Angeli FS, Sanz-Ruiz R, Vaughn WK, Zheng Y, Baimbridge F, Canales J, Cardoso CO, Assad JA, Falotico R, Perin EC.
    Catheter Cardiovasc Interv; 2009 May 01; 73(6):801-8. PubMed ID: 19309735
    [Abstract] [Full Text] [Related]

  • 15. Survival of endothelial cells in vitro on Paclitaxel-loaded coronary stents.
    Prasad CK, Resmi KR, Krishnan LK, Vaishnav R.
    J Biomater Appl; 2005 Apr 01; 19(4):271-86. PubMed ID: 15788425
    [Abstract] [Full Text] [Related]

  • 16. Two-dimensional fluorescence in-gel electrophoresis of coronary restenosis tissues in minipigs: increased adipocyte fatty acid binding protein induces reactive oxygen species-mediated growth and migration in smooth muscle cells.
    Lu L, Wang YN, Sun WH, Liu ZH, Zhang Q, Pu LJ, Yang K, Wang LJ, Zhu ZB, Meng H, Yang P, Du R, Chen QJ, Wang LS, Yu H, Shen WF.
    Arterioscler Thromb Vasc Biol; 2013 Mar 01; 33(3):572-80. PubMed ID: 23372061
    [Abstract] [Full Text] [Related]

  • 17. Molecular basis of different outcomes for drug-eluting stents that release sirolimus or tacrolimus.
    Giordano A.
    Curr Opin Drug Discov Devel; 2010 Mar 01; 13(2):159-68. PubMed ID: 20205050
    [Abstract] [Full Text] [Related]

  • 18. Experimental efficacy of an everolimus eluting cobalt chromium stent.
    Carter AJ, Brodeur A, Collingwood R, Ross S, Gibson L, Wang CA, Haller S, Coleman L, Virmani R.
    Catheter Cardiovasc Interv; 2006 Jul 01; 68(1):97-103. PubMed ID: 16755598
    [Abstract] [Full Text] [Related]

  • 19. Effects of cytochalasin D-eluting stents on intimal hyperplasia in a porcine coronary artery model.
    Salu KJ, Bosmans JM, Huang Y, Hendriks M, Verhoeven M, Levels A, Cooper S, De Scheerder IK, Vrints CJ, Bult H.
    Cardiovasc Res; 2006 Feb 01; 69(2):536-44. PubMed ID: 16386237
    [Abstract] [Full Text] [Related]

  • 20. The effects of vinblastine on smooth muscle cells in vitro: evaluation of a therapeutic window for the treatment of restenosis.
    Gallagher H, Carroll WM, Rochev Y.
    J Cardiovasc Pharmacol; 2010 Apr 01; 55(4):399-407. PubMed ID: 20147845
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.